Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/news
Clear filters and search
Format
photo
Tags
anti obesity medication
health medical pharma
novo nordisk
semaglutide
business finance
eli lilly
eli lilly and company
peptide hormones
peptide therapeutics
pharmaceutical industry
wegovy
glp 1
glp 1 receptor agonist
glucagon like peptide 1
hims hers
johnson johnson
research and development in the united states
tirzepatide
us food and drug administration
zepbound
albert bourla
amgen
amycretin
andy hsieh
anti diabetic drugs
ascendis pharma
big pharma
caroline litchfield
darzalex
donald trump
elite pharmaceuticals inc
first trump tariffs
food and drug administration
in denmark
in science
johnson and johnson
kennedy
lars fruergaard
lars fruergaard jorgensen
liraglutide
What
drug
loss
4
×
news
4
×
ozempic
pharma
quarter
4
×
read
4
×
roundup
4
×
sales
weight
blockbuster
company’s
eli
nordisk
novo
year
expectations
j
johnson
johnson’s
lilly’s
new
popular
potential
wegovy
zepbound
administration
based
bets
billion
boom
boost
boosts
cancer
continued
ct
current
darzalex
denmark
despite
Language
unset
Current search:
news
×
read
×
roundup
×
loss
×
quarter
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}